FDA Inspection 826556 — Seqirus Vaccines Limited

Seqirus Vaccines Limited — FEI 3002806949

The FDA completed an inspection of Seqirus Vaccines Limited on March 19, 2013 in Liverpool. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 19, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Liverpool (United Kingdom)